“Omega-3 PUFAs are polyunsaturated fatty acids having potential health benefits and are important for normal metabolism. Growing awareness about the benefits of Omega-3 along with increased focus on preventive healthcare among consumers is driving the Omega-3 market globally. Emerging applications such as pharmaceuticals and infant formulas are poised to exhibit higher demand of Omega-3 during the forecast period.
The report provides detailed analysis of the type of acid which are DHA (docosahexaenoic acid), EPA (Eicosapentaenoic Acid) and ALA (Alpha-linoleic acid). DHA and EPA account for major share due to their application in reducing the risk of cardio-vascular diseases. The market values and growth rates have been estimated on the basis of source of the fatty acids such as anchovy/sardines, concentrates, algae, tuna, salmon and so on. The market is also segmented based on its end-use, which includes dietary supplements, pharmaceuticals, infant formula, food & beverage and others.
In this report, forecast values for the Omega-3 market on the basis of major regions such as North America, Europe, Asia-Pacific and Rest of the World are provided. Key countries are covered in the report and market forecasts for each region are provided as well. North America has been leading the market; whereas, Asia-Pacific market region is estimated to witness the highest growth fuelled by rising demand for Omega-3 PUFA dietary supplements. Furthermore, the report includes analysis on patents and competitive landscape. It also identifies the drivers and restrains for the market with detailed analysis of trends, opportunities and challenges.
”
“1. Global Omega-3 PUFA Market Overview
2. Executive Summary
3. Global Omega-3 PUFA Market Landscape
3.1. Market Share Analysis
3.2. Patent Analysis
3.3. Product Benchmarking
4. Global Omega-3 PUFA Market – Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of Global Omega-3 PUFA Industry
4.4.1. Power of Suppliers
4.4.2. Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New entrants
4.4.5. Degree of Competitive Rivalry
5. Global Omega-3 PUFA Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
6. Global Omega-3 PUFA Market – By Type
6.1. DHA (docosahexaenoic acid)
6.2. EPA (eicosapentaenoic acid)
6.3. ALA (Alpha-linoleic acid)
7. Global Omega-3 PUFA Market – By Source
7.1. Marine
7.1.1. Cod
7.1.2. Salmon
7.1.3. Krill
7.1.4. Anchovy
7.1.5. Other Marine Sources
7.2. Plant
7.2.1. Flax seeds
7.2.2. Chia
7.2.3. Hemp
7.2.4. Canola
7.3. Algae
8. Global Omega-3 PUFA Market – By form
8.1. Pills
8.2. Oils
8.3. Powder
9. Global Omega-3 PUFA Market – Application
9.1. Infant Foods
9.2. Dietary Supplements
9.3. Pharmaceuticals
9.4. Food and Beverage
9.5. Others
10. Global Omega-3 PUFA Market -Geographic Analysis
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.1.3. Mexico
10.2. APAC
10.2.1. China
10.2.2. India
10.2.3. Japan
10.2.4. Australia and New Zealand
10.2.5. Rest of APAC
10.3. Europe
10.3.1. U.K.
10.3.2. France
10.3.3. Germany
10.3.4. Italy
10.3.5. Russia
10.3.6. Rest of Europe
10.4. RoW
10.4.1. Africa
10.4.2. Middle East
10.4.3. South America
11. Market Entropy
11.1. New Product Launches
11.2. M&As and Expansions
12. Company Profiles (Business Overview, Financials, Strategic Analysis of Top Companies, Developments, Product Portfolio)
12.1. Aker BioMarine(Norway)
12.2. Axellus(Denmark)
12.3. BASF SE(Germany)
12.4. Bioprocess Algae LLC(U.S.)
12.5. Carlson Laboratories(U.S.)
12.6. Croda Internatioal Plc.(England)
12.7. Royal DSM(The Netherlands)
12.8. FMC Corporation(U.S.)
12.9. GC Rieber Oils(Norway)
12.10. Golden Omega(Chile)
12.11. KD Pharma Bexbach GmbH (Germany)
12.12. Luhua Biomarine Co., Ltd.(China)
12.13. Marine Ingredients(U.S.)
12.14. Neptune Technologies & Bioressources Inc.(Canada)
12.15. Omega Protein Corporation(U.S.)
12.16. Omega Natural Ltd.(U.S.)
12.17. Pharma Marine AS(Norway)
12.18. Sapphire Energy(U.S.)
12.19. Smit & Zoon(The Netherlands)
12.20. Solutex(Spain)
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
13. Global Omega-3 PUFA Market Appendix
13.1. List of Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Expert Insights
13.5. Disclaimer”
“12.1. Aker BioMarine(Norway)
12.2. Axellus(Denmark)
12.3. BASF SE(Germany)
12.4. Bioprocess Algae LLC(U.S.)
12.5. Carlson Laboratories(U.S.)
12.6. Croda Internatioal Plc.(England)
12.7. Royal DSM(The Netherlands)
12.8. FMC Corporation(U.S.)
12.9. GC Rieber Oils(Norway)
12.10. Golden Omega(Chile)
12.11. KD Pharma Bexbach GmbH (Germany)
12.12. Luhua Biomarine Co., Ltd.(China)
12.13. Marine Ingredients(U.S.)
12.14. Neptune Technologies & Bioressources Inc.(Canada)
12.15. Omega Protein Corporation(U.S.)
12.16. Omega Natural Ltd.(U.S.)
12.17. Pharma Marine AS(Norway)
12.18. Sapphire Energy(U.S.)
12.19. Smit & Zoon(The Netherlands)
12.20. Solutex(Spain)”
